Aghiad Chamdin
28050 Grand River Avenue, 
Farmington Hills, MI 

Overview

Aghiad Chamdin is a Pediatrics provider in Farmington Hills, Michigan. Dr. Chamdin has been practicing medicine for over 35 years. His top areas of expertise are Febrile Neutropenia, Gliomatosis Cerebri, Neurofibromatosis Type 1 (NF1), and Bone Marrow Aspiration. Dr. Chamdin is currently accepting new patients.

His clinical research consists of co-authoring 6 peer reviewed articles and participating in 21 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

University Of Damascus Faculty Of Human Medicine, 1991

Residency

Henry Ford St. John Hospital

Specialties

Pediatrics

Licenses

Pediatric Hematology-Oncology in MI

Board Certifications

American Board Of Pediatrics
American Board Of Pediatrics

Fellowships

Wayne State University School of Medicine GME

Hospital Affiliations

Corewell Health Farmington Hills Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 7 Less Insurance Carriers -

Locations

Corewell Health Hospitalist - Farmington Hills
28050 Grand River Avenue, Farmington Hills, MI 48336

Additional Areas of Focus

Dr. Chamdin has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


21 Clinical Trials

A Phase 3 Randomized Trial for Patients With De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 With GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients With FLT3 Mutations
Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old With First Relapse
A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab With or Without Eflornithine (DFMO) in Children With Relapsed, Refractory or Progressive Neuroblastoma
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Renal Tumors Classification, Biology, and Banking Study
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
View 15 Less Clinical Trials
Similar Doctors
Nancy A. Mcnamara
Expertise in
16
conditions
Pediatrics | Pediatric Neurology
Expertise in
16
conditions
Pediatrics | Pediatric Neurology

Corewell Health William Beaumont University Hospital Adult Neurosurgery Florence & Richard McBrien Pediatric Neuroscience Center - 3555 W 13 Mile Rd

3555 West 13 Mile Road, Suite N300, 
Royal Oak, MI 
 (8.2 miles away)
Experience:
16+ years
Languages Spoken:
English
Accepting New Patients

Nancy Mcnamara is a Pediatrics specialist and a Pediatric Neurologist in Royal Oak, Michigan. Dr. Mcnamara has been practicing medicine for over 16 years is highly rated in 16 conditions, according to our data. Her top areas of expertise are Seizures, Epilepsy in Children, Lennox-Gastaut Syndrome (LGS), and Generalized Tonic-Clonic Seizure. Dr. Mcnamara is currently accepting new patients.

Expertise in
7
conditions
Expertise in
7
conditions

Henry Ford Medical Center-Fairlane

19401 Hubbard Dr, 
Dearborn, MI 
 (10.0 miles away)
Languages Spoken:
English

Kristina Suson is a Pediatrics provider in Dearborn, Michigan. Dr. Suson is highly rated in 7 conditions, according to our data. Her top areas of expertise are Cloacal Exstrophy, Exstrophy of the Bladder, Undescended Testicle, Nephrectomy, and Orchiectomy.

Expertise in
7
conditions
Expertise in
7
conditions

Office

3901 Beaubien St Fl 2, 
Detroit, MI 
 (15.1 miles away)
Languages Spoken:
English

Seetha Shankaran is a Pediatrics provider in Detroit, Michigan. Dr. Shankaran is highly rated in 7 conditions, according to our data. Her top areas of expertise are Premature Infant, Asphyxia Neonatorum, Infant Respiratory Distress Syndrome, and Intraventricular Hemorrhage of the Newborn.

Frequently Asked Questions about Dr. Aghiad Chamdin

How do I make an appointment with Dr. Aghiad Chamdin?

You can book an appointment with Dr. Aghiad Chamdin by calling their office at 947-521-8000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Aghiad Chamdin a top-rated expert for Febrile Neutropenia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Aghiad Chamdin is classified as an Experienced expert for Febrile Neutropenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Aghiad Chamdin specialize in?

While Dr. Aghiad Chamdin is a Pediatrics, they have specific expertise in Febrile Neutropenia, Bone Marrow Aspiration, and Gliomatosis Cerebri. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.

Does Dr. Aghiad Chamdin participate in research or clinical trials?

Yes. Dr. Aghiad Chamdin has published 6 articles and abstracts on conditions like Febrile Neutropenia. You can view a list of Dr. Aghiad Chamdin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Aghiad Chamdin accept my insurance?

Dr. Aghiad Chamdin accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 947-521-8000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chamdin's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile